{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:35:03Z","timestamp":1790753703647,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,5,21]],"date-time":"2016-05-21T00:00:00Z","timestamp":1463788800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Novartis Pharma AG"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s12020-016-0978-6","type":"journal-article","created":{"date-parts":[[2016,5,24]],"date-time":"2016-05-24T01:52:46Z","timestamp":1464054766000},"page":"516-523","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Late-night salivary cortisol may be valuable for assessing treatment response in patients with Cushing\u2019s disease: 12-month, Phase III pasireotide study"],"prefix":"10.1007","volume":"54","author":[{"given":"James W.","family":"Findling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Fleseriu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Newell-Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Petersenn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Pivonello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Kandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto M.","family":"Pedroncelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly M. K.","family":"Biller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,21]]},"reference":[{"key":"978_CR1","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","volume":"93","author":"LK Nieman","year":"2008","unstructured":"L.K. Nieman, B.M. Biller, J.W. Findling et al., The diagnosis of Cushing\u2019s syndrome: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 93, 1526\u20131540 (2008)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"978_CR2","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1210\/jc.2012-3200","volume":"98","author":"X Bertagna","year":"2013","unstructured":"X. Bertagna, L. Guignat, Approach to the Cushing\u2019s disease patient with persistent\/recurrent hypercortisolism after pituitary surgery. J. Clin. Endocrinol. Metab. 98, 1307\u20131318 (2013)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"978_CR3","first-page":"221","volume-title":"Handbook of Clinical Neurology. Clinical Neuroendocrinology","author":"NA Tritos","year":"2014","unstructured":"N.A. Tritos, B.M. Biller, Cushing\u2019s disease, in Handbook of Clinical Neurology. Clinical Neuroendocrinology, vol. 124, ed. by E. Fliers, M. Korbonits, J.A. Romijn (Elsevier, Amsterdam, 2014), pp. 221\u2013234"},{"key":"978_CR4","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/MED.0b013e3283487193","volume":"18","author":"KI Alexandraki","year":"2011","unstructured":"K.I. Alexandraki, A.B. Grossman, Is urinary free cortisol of value in the diagnosis of Cushing\u2019s syndrome? Curr. Opin. Endocrinol. Diabetes Obes. 18, 259\u2013263 (2011)","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"978_CR5","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1210\/jc.2007-0596","volume":"92","author":"F Pecori Giraldi","year":"2007","unstructured":"F. Pecori Giraldi, A.G. Ambrogio, M. De Martin et al., Specificity of first-line tests for the diagnosis of Cushing\u2019s syndrome: assessment in a large series. J. Clin. Endocrinol. Metab. 92, 4123\u20134129 (2007)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"978_CR6","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1210\/jcem.83.2.4555","volume":"83","author":"MV Mericq","year":"1998","unstructured":"M.V. Mericq, G.B. Cutler Jr, High fluid intake increases urine free cortisol excretion in normal subjects. J. Clin. Endocrinol. Metab. 83, 682\u2013684 (1998)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"978_CR7","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/cen.12259","volume":"80","author":"S Petersenn","year":"2014","unstructured":"S. Petersenn, J. Newell-Price, J. Findling et al., High variability in baseline urinary free cortisol values in patients with Cushing\u2019s disease. Clin. Endocrinol. (Oxf.) 80, 261\u2013269 (2014)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"978_CR8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s12020-012-9855-0","volume":"43","author":"SA Doi","year":"2013","unstructured":"S.A. Doi, J. Clark, A.W. Russell, Concordance of the late night salivary cortisol in patients with Cushing\u2019s syndrome and elevated urine-free cortisol. Endocrine 43, 327\u2013333 (2013)","journal-title":"Endocrine"},{"key":"978_CR9","doi-asserted-by":"crossref","first-page":"335","DOI":"10.4158\/EP09023OR","volume":"15","author":"T Carroll","year":"2009","unstructured":"T. Carroll, H. Raff, J.W. Findling, Late-night salivary cortisol for the diagnosis of Cushing syndrome: a meta-analysis. Endocr. Pract. 15, 335\u2013342 (2009)","journal-title":"Endocr. Pract."},{"key":"978_CR10","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.1210\/jc.2004-2264","volume":"90","author":"A Viardot","year":"2005","unstructured":"A. Viardot, P. Huber, J.J. Puder et al., Reproducibility of nighttime salivary cortisol and its use in the diagnosis of hypercortisolism compared with urinary free cortisol and overnight dexamethasone suppression test. J. Clin. Endocrinol. Metab. 90, 5730\u20135736 (2005)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"978_CR11","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1210\/jc.2002-020534","volume":"87","author":"DA Papanicolaou","year":"2002","unstructured":"D.A. Papanicolaou, N. Mullen, I. Kyrou et al., Nighttime salivary cortisol: a useful test for the diagnosis of Cushing\u2019s syndrome. J. Clin. Endocrinol. Metab. 87, 4515\u20134521 (2002)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"978_CR12","first-page":"2681","volume":"83","author":"H Raff","year":"1998","unstructured":"H. Raff, J.L. Raff, J.W. Findling, Late-night salivary cortisol as a screening test for Cushing\u2019s syndrome. J. Clin. Endocrinol. Metab. 83, 2681\u20132686 (1998)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"978_CR13","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1055\/s-2005-837667","volume":"113","author":"M Trilck","year":"2005","unstructured":"M. Trilck, J. Flitsch, D.K. Ludecke et al., Salivary cortisol measurement\u2014a reliable method for the diagnosis of Cushing\u2019s syndrome. Exp. Clin. Endocrinol. Diabetes 113, 225\u2013230 (2005)","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"978_CR14","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1210\/jc.2003-030871","volume":"88","author":"G Arnaldi","year":"2003","unstructured":"G. Arnaldi, A. Angeli, A.B. Atkinson et al., Diagnosis and complications of Cushing\u2019s syndrome: a consensus statement. J. Clin. Endocrinol. Metab. 88, 5593\u20135602 (2003)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"978_CR15","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0140-6736(06)68699-6","volume":"367","author":"J Newell-Price","year":"2006","unstructured":"J. Newell-Price, X. Bertagna, A.B. Grossman et al., Cushing\u2019s syndrome. Lancet 367, 1605\u20131617 (2006)","journal-title":"Lancet"},{"key":"978_CR16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11102-013-0475-3","volume":"17","author":"M Barbot","year":"2014","unstructured":"M. Barbot, N. Albiger, F. Ceccato et al., Combination therapy for Cushing\u2019s disease: effectiveness of two schedules of treatment. Should we start with cabergoline or ketoconazole? Pituitary 17, 109\u2013117 (2014)","journal-title":"Pituitary"},{"key":"978_CR17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11102-014-0557-x","volume":"18","author":"L Trementino","year":"2015","unstructured":"L. Trementino, M. Cardinaletti, C. Concettoni et al., Salivary cortisol is a useful tool to assess the early response to pasireotide in patients with Cushing\u2019s disease. Pituitary 18, 60\u201367 (2015)","journal-title":"Pituitary"},{"key":"978_CR18","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s11102-012-0452-2","volume":"16","author":"R Pas van der","year":"2012","unstructured":"R. van der Pas, C. de Bruin, A.M. Pereira et al., Cortisol diurnal rhythm and quality of life after successful medical treatment of Cushing\u2019s disease. Pituitary 16, 536\u2013544 (2012)","journal-title":"Pituitary"},{"key":"978_CR19","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1530\/eje.0.1460707","volume":"146","author":"C Bruns","year":"2002","unstructured":"C. Bruns, I. Lewis, U. Briner et al., SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile. Eur. J. Endocrinol. 146, 707\u2013716 (2002)","journal-title":"Eur. J. Endocrinol."},{"key":"978_CR20","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1056\/NEJMoa1105743","volume":"366","author":"A Colao","year":"2012","unstructured":"A. Colao, S. Petersenn, J. Newell-Price et al., A 12-month Phase 3 study of pasireotide in Cushing\u2019s disease. N. Engl. J. Med. 366, 914\u2013924 (2012)","journal-title":"N. Engl. J. Med."},{"key":"978_CR21","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/cen.12431","volume":"81","author":"R Pivonello","year":"2014","unstructured":"R. Pivonello, S. Petersenn, J. Newell-Price et al., Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing\u2019s disease: results from a Phase III study. Clin. Endocrinol. (Oxf.) 81, 408\u2013417 (2014)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"978_CR22","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.1210\/jc.2008-1171","volume":"93","author":"CA Carrasco","year":"2008","unstructured":"C.A. Carrasco, J. Coste, L. Guignat et al., Midnight salivary cortisol determination for assessing the outcome of transsphenoidal surgery in Cushing\u2019s disease. J. Clin. Endocrinol. Metab. 93, 4728\u20134734 (2008)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"978_CR23","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1210\/jc.2008-1542","volume":"94","author":"ML Nunes","year":"2009","unstructured":"M.L. Nunes, S. Vattaut, J.B. Corcuff et al., Late-night salivary cortisol for diagnosis of overt and subclinical Cushing\u2019s syndrome in hospitalized and ambulatory patients. J. Clin. Endocrinol. Metab. 94, 456\u2013462 (2009)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"978_CR24","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/cen.12534","volume":"82","author":"M Danet-Lamasou","year":"2014","unstructured":"M. Danet-Lamasou, J. Asselineau, P. Perez et al., Accuracy of repeated measurements of late-night salivary cortisol to screen for early-stage recurrence of Cushing\u2019s disease following pituitary surgery. Clin. Endocrinol. (Oxf.) 82, 260\u2013266 (2014)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"978_CR25","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1530\/EJE-11-0945","volume":"166","author":"T Deutschbein","year":"2012","unstructured":"T. Deutschbein, M. Broecker-Preuss, J. Flitsch et al., Salivary cortisol as a diagnostic tool for Cushing\u2019s syndrome and adrenal insufficiency: improved screening by an automatic immunoassay. Eur. J. Endocrinol. 166, 613\u2013618 (2012)","journal-title":"Eur. J. Endocrinol."},{"key":"978_CR26","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1210\/jc.2013-4262","volume":"99","author":"PC Elias","year":"2014","unstructured":"P.C. Elias, E.Z. Martinez, B.F. Barone et al., Late-night salivary cortisol has a better performance than urinary free cortisol in the diagnosis of Cushing\u2019s syndrome. J. Clin. Endocrinol. Metab. 99, 2045\u20132051 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"978_CR27","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1530\/EJE-11-0424","volume":"165","author":"RB Khalil","year":"2011","unstructured":"R.B. Khalil, C. Baudry, L. Guignat et al., Sequential hormonal changes in 21 patients with recurrent Cushing\u2019s disease after successful pituitary surgery. Eur. J. Endocrinol. 165, 729\u2013737 (2011)","journal-title":"Eur. J. Endocrinol."},{"key":"978_CR28","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11102-011-0333-0","volume":"15","author":"H Raff","year":"2012","unstructured":"H. Raff, Cushing\u2019s syndrome: diagnosis and surveillance using salivary cortisol. Pituitary 15, 64\u201370 (2012)","journal-title":"Pituitary"},{"key":"978_CR29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4158\/EP14451.CO","volume":"21","author":"JW Findling","year":"2015","unstructured":"J.W. Findling, Evolution, global warming, smart phones, and late-night salivary cortisol. Endocr. Pract. 21, 205\u2013207 (2015)","journal-title":"Endocr. Pract."},{"key":"978_CR30","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nrendo.2010.192","volume":"6","author":"H Raff","year":"2010","unstructured":"H. Raff, J.W. Findling, Biomarkers: salivary cortisol or cortisone? Nat. Rev. Endocrinol. 6, 658\u2013660 (2010)","journal-title":"Nat. Rev. Endocrinol."},{"key":"978_CR31","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s12020-013-0013-0","volume":"44","author":"H Raff","year":"2013","unstructured":"H. Raff, Update on late-night salivary cortisol for the diagnosis of Cushing\u2019s syndrome: methodological considerations. Endocrine 44, 346\u2013349 (2013)","journal-title":"Endocrine"},{"key":"978_CR32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ecl.2014.10.005","volume":"44","author":"H Raff","year":"2015","unstructured":"H. Raff, Cushing syndrome: update on testing. Endocrinol. Metab. Clin. N. Am. 44, 43\u201350 (2015)","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"978_CR33","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.clinbiochem.2011.02.003","volume":"44","author":"G Casals","year":"2011","unstructured":"G. Casals, L. Foj, M.J. de Osaba, Day-to-day variation of late-night salivary cortisol in healthy voluntaries. Clin. Biochem. 44, 665\u2013668 (2011)","journal-title":"Clin. Biochem."},{"key":"978_CR34","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1080\/00365510701819127","volume":"68","author":"AM Hansen","year":"2008","unstructured":"A.M. Hansen, A.H. Garde, R. Persson, Sources of biological and methodological variation in salivary cortisol and their impact on measurement among healthy adults: a review. Scand. J. Clin. Lab. Invest. 68, 448\u2013458 (2008)","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"978_CR35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jpor.2011.04.004","volume":"56","author":"S Matsuda","year":"2012","unstructured":"S. Matsuda, T. Yamaguchi, K. Okada et al., Day-to-day variations in salivary cortisol measurements. J. Prosthodont. Res. 56, 37\u201341 (2012)","journal-title":"J. Prosthodont. Res."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-016-0978-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-016-0978-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-016-0978-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-016-0978-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T19:17:32Z","timestamp":1553627852000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-016-0978-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,21]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["978"],"URL":"https:\/\/doi.org\/10.1007\/s12020-016-0978-6","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,21]]}}}